Last updated: 2026-10-12 20:10:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $57.58, with a market capitalization of $120.77B and a P/E ratio of 13.01. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$120.77B | |
$60.11 | |
$81.44 | |
$16.00 | |
$59.12 | |
19.43M | |
11.26M | |
13.01 | |
$68.64 | |
$42.52 | |
4.22% | |
-- |
Bristol-Myers Squibb Co. (BMY) is trading at $57.27 in after-hours trading as of 2026-10-12 19:53:00, down 3.13% ($1.85) from the regular-session close of $59.12.
After-hours trading shows how investors are pricing BMY after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $61.46 to $57.58, representing a decline of 6.32% ($3.88).
The stock traded between $56.81 and $63.47 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 11.89 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 57.6%
BMY is currently trading at $57.58, placing it 57.6% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.